ovarian-cancer

Documents about ovarian-cancer

• dataset#922302Figshare
• Evaluating the Efficacy of Hyperthermic Intraperitoneal Treatment to Enhance the Sensitivity of Immune Checkpoint Inhibitor in Patients With Advanced Ovarian Cancer： A Single-arm Study#146466ClinicalTrials.gov
• TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors#888287ClinicalTrials.gov
• Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women#908347ClinicalTrials.gov
• Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors#195313ClinicalTrials.gov
• Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program#863539ClinicalTrials.gov
• A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors#893583ClinicalTrials.gov
• Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors#916709ClinicalTrials.gov
• Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study#665183HAL (France)
• Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity#885440ClinicalTrials.gov
• Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study#642253eScholarship
• Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome#675878eScholarship
• A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer#811760ClinicalTrials.gov
• Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients#908834ClinicalTrials.gov
• Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive#833852ClinicalTrials.gov
• Genetic Risk: Whether, When, and How to Tell Adolescents#805574ClinicalTrials.gov
• Molecular targeted therapy in combination with chemotherapy for the treatment of platinum-resistant/refractory ovarian cancer (PROC): a systematic review and network meta-analysis#4614Europe PMC
• Activation of PAF-Receptor and Pleiotropic Effects on Tyrosine Phospho-EGFR/Src/FAK/Paxillin in Ovarian Cancer#166632Zenodo (CERN)
• Baseline value and longitudinal kinetics of circulating nucleosomes during neo-adjuvant chemotherapy in newly diagnosed ovarian cancer: Results from a GINECO/GINEGEPS study of the randomized phase II CHIVA trial#374385HAL (France)
• Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting#873733ClinicalTrials.gov
• Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors#839793ClinicalTrials.gov
• A Translational Study to Explore and Overcome Metabolic-driven Resistance Mechanisms to Standard Chemotherapy in High-grade Ovarian Cancer#849129ClinicalTrials.gov
• A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors#903872ClinicalTrials.gov
• TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers#890580ClinicalTrials.gov
• Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors#866348ClinicalTrials.gov
• The Better, Harder, Faster, Stronger Study#864188ClinicalTrials.gov
• The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery#914176ClinicalTrials.gov
• Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)#230495ClinicalTrials.gov
• [A Transformer-based model using laboratory indicators efficiently differentiates ovarian cancer].#143170NCBI PubMed Central
• Hypertension and ovarian cancer risk: a meta-analysis of observational studies.#423137NCBI PubMed Central
• Complementary intra- and extracellular AGR2 activities support epithelial ovarian cancer cell aggressiveness#677163HAL (France)
• A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors#831021ClinicalTrials.gov
• Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies#898416ClinicalTrials.gov
• PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade#14277HAL (France)
• MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer#826793ClinicalTrials.gov
• Continued Access to RXDX-105#867496ClinicalTrials.gov
• Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101#877145ClinicalTrials.gov
• A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies#804957ClinicalTrials.gov
• Safety Study of MGD009 in B7-H3-expressing Tumors#894828ClinicalTrials.gov
• Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer#829752ClinicalTrials.gov
• A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications#892445ClinicalTrials.gov
• Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk#177971Lund University Publications
• Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer#839444ClinicalTrials.gov
• Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study#346823ClinicalTrials.gov
• A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies#895945ClinicalTrials.gov
• Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors#875304ClinicalTrials.gov
• Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma#918091ClinicalTrials.gov
• A Deep Learning-Based Assessment Pipeline for Intraepithelial and Stromal Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Carcinoma#468525Kyoto University Research Information Repository
• A Deep Learning-Based Assessment Pipeline for Intraepithelial and Stromal Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Carcinoma#468553Kyoto University Research Information Repository
• FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophages#612297eScholarship